cyclopentane has been researched along with fingolimod hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charles, EJ; Huerter, ME; Johnston, WF; Kron, IL; Laubach, VE; Lynch, KR; Sharma, AK; Stone, ML; Zhao, Y | 1 |
| Busey, GW; Desai, BN; Doyle, CA; Huang, T; Iobst, WH; Kennedy, JA; Lynch, KR; Manjegowda, MC; Naphade, SS; Seegren, PV | 1 |
2 other study(ies) available for cyclopentane and fingolimod hydrochloride
| Article | Year |
|---|---|
Sphingosine-1-phosphate receptor 1 agonism attenuates lung ischemia-reperfusion injury.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cyclopentanes; Cytokines; Fingolimod Hydrochloride; Flow Cytometry; Immunoenzyme Techniques; Immunosuppressive Agents; Lung Injury; Lysophospholipids; Mice; Mice, Inbred C57BL; Propylene Glycols; Receptors, Lysosphingolipid; Reperfusion Injury; Sphingosine; Sphingosine-1-Phosphate Receptors | 2015 |
Analogs of FTY720 inhibit TRPM7 but not S1PRs and exert multimodal anti-inflammatory effects.
Topics: Cyclopentanes; Fingolimod Hydrochloride; Phosphorylation; TRPM Cation Channels | 2024 |